Current scenario on non-nucleoside reverse transcriptase inhibitors  (2018-present) - ScienceDirect

Current scenario on non-nucleoside reverse transcriptase inhibitors (2018-present) - ScienceDirect

4.5
(163)
Write Review
More
$ 16.99
Add to Cart
In stock
Description

Current scenario on non-nucleoside reverse transcriptase

Non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Current scenario on non-nucleoside reverse transcriptase

Current scenario on non-nucleoside reverse transcriptase

The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside

The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside

Non-nucleoside reverse transcriptase inhibitors (NNRTIs): a brief

Approved HIV reverse transcriptase inhibitors in the past decade

New indolylarylsulfone non-nucleoside reverse transcriptase